20P Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)

José Trigo, B.C. Cho, K. Park, N. Girard, Santiago Viteri, Pilar Garrido, Matthew Krebs, M. Thayu, R.E. Knoblauch, J. Xie, J.M. Bauml, R.W. Schnepp, A. Londhe, P. Mahadevia, N. Leighl

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S38-S39
JournalAnnals of Oncology
Publication statusPublished - 1 Apr 2022

Cite this